Trial Profile
Clinical Trials Insight: 700043059
Status:
Not stated
Phase of Trial:
Phase I
Latest Information Update: 06 Apr 2009
Price :
$35
*
At a glance
- Drugs BC 7013 (Primary)
- Indications Bacterial infections; Skin infections
- Focus Adverse reactions
- Sponsors Nabriva Therapeutics
- 06 Apr 2009 New trial record.